Delivery Order SPE2DB20D2014-SPE2DB24FD01T

Award Date 9/12/24
Potential Completion Date 9/13/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,253.12 firm fixed-price delivery order is for the supply of ATROPINE 1 MG/ML VIALML, a critical medical product, with a completion date of February 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,311.90 firm-fixed-price delivery order is for the supply of 1 milligram per milliliter vials of the medication atropine. The contract has an ultimate completion date of September 10, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract as part of the agency's broader Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,679.08, is a delivery order for 4,567,467,615 units of 1 mg/mL Atropine vials. It is a firm fixed-price contract with a period of performance through March 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This $1,567.17 federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,077.25 firm fixed-price delivery order covers the supply of Atropine 1 mg/10 ml syringes, with a contract completion date of December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,691.30, is for the delivery of atropine 1mg/1ml vials, a critical medical product used in various healthcare settings. The contract is structured as a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $13,887.72 firm fixed-price delivery order is for the supply of Atropine 1 mg/ml vials, a medication used for various medical purposes. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,025.47 firm fixed-price delivery order is for the supply of 4,568,116,031 units of 8 mg/20 ml atropine vials. The contract has an ultimate completion date of May 5, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atropine 1 mg/ml vials, a critical medical commodity, with a ceiling value of $1,043.17 and a completion date of February 24, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,644.31 firm fixed price delivery order is for the medical supply ATROPINE 1 MG/ML VIALML, with a completion date of January 23, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FD01T
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Amerisourcebergen Drug Corp, a major pharmaceutical supplier. The $2,753.90 firm-fixed-price delivery order is for the supply of 0.4 mg/mL vials of the medication atropine, with a period of performance through September 13, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs and facilities worldwide. The award does not utilize a set-aside designation.

Generated 12/12/24, 9:03 AM